InsiderSignalSign in

← Insider buys

Paul A Mahon has sold UTHR and made no open-market buys since Aug 2021

EVP and General Counsel at United Therapeutics Corporation

SEC CIK 0001231589 · Filings on SEC.gov ↗

$0Bought

$186.8MSold

NoneLast buy

Every filing

85 filings since Aug 2021, newest first

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.5M−15.5%Oct 16

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.7M−15.5%Oct 1

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.1M−15.5%Sep 18

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.0M−15.5%Sep 3

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.3M−15.5%Aug 21

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.3M−15.5%Aug 6

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.4M−15.5%Jul 16

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.6M−15.5%Jul 2

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.5M−15.5%Jun 18

UNITED THERAPEUTICS Corp

EVP and General Counsel

$4.5M−15.5%Jun 4

United Therapeutics Corp

EVP and General Counsel

$4.7M−16.0%May 21

United Therapeutics Corp

EVP and General Counsel

$4.9M−16.0%May 7

United Therapeutics Corp

EVP and General Counsel

$4.8M−16.0%Apr 16

United Therapeutics Corp

EVP and General Counsel

$4.7M−16.0%Apr 2

United Therapeutics Corp

EVP and General Counsel

$4.4M−16.0%Mar 19

United Therapeutics Corp

EVP and General Counsel

$4.0M−18.0%Mar 5

United Therapeutics Corp

EVP and General Counsel

$4.0M−18.0%Feb 19

United Therapeutics Corp

EVP and General Counsel

$4.0M−18.0%Feb 5

United Therapeutics Corp

EVP and General Counsel

$3.9M−18.0%Jan 15

United Therapeutics Corp

EVP and General Counsel

$4.0M−18.0%Jan 2

United Therapeutics Corp

EVP and General Counsel

$5.6M−23.0%Dec 29

United Therapeutics Corp

EVP and General Counsel

$5.3M−23.0%Dec 12

United Therapeutics Corp

EVP and General Counsel

$5.3M−23.0%Nov 26

United Therapeutics Corp

EVP and General Counsel

$2.8M−17.0%Nov 22

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Apr 4

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Mar 22

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Mar 7

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Feb 15

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Feb 2

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Jan 18

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Jan 5

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Dec 26

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Dec 7

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Nov 17

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Nov 3

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Oct 20

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Oct 10

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Sep 22

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Sep 8

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Aug 18

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Aug 4

United Therapeutics Corp

EVP and General Counsel

$610K−6.0%Jul 24

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Jul 7

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Jun 15

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Jun 1

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%May 18

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%May 4

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Apr 20

United Therapeutics Corp

EVP and General Counsel

$1.4M−14.0%Apr 7

United Therapeutics Corp

EVP and General Counsel

$1.3M−14.0%Mar 17

About Paul A Mahon

MAHON PAUL A. is a Person and serves as Executive Vice President, General Counsel, and Corporate Secretary of United Therapeutics Corporation.( He has been with the company since its founding era: he served as General Counsel and Corporate Secretary from United Therapeutics’ inception in 1996, joined full-time in 2001 as Senior Vice President, General Counsel and Corporate Secretary, and was promoted in 2003 to his current executive vice president role.(

Before joining United Therapeutics full-time, Mahon supported the company beginning in 1996 as the principal and managing partner of a law firm focused on technology and media law.( Public filings and executive profiles also identify him as J.D., and recent insider-trading reports confirm his continued role as a senior executive at United Therapeutics.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.